CHPA Regulatory, Scientific Affairs To Be Headed By P&G’s Bierer
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble exec Douglas Bierer, PhD, will succeed 18-year Consumer Healthcare Products Association veteran William Soller, PhD, in leading the group's regulatory and scientific affairs department effective May 5
You may also be interested in...
CHPA To Lobby Against FDA-Initiated Rx-To-OTC Switches
Congress should discourage FDA from pursuing Rx-to-OTC switches without the drug sponsor's approval, the Consumer Healthcare Products Association asserts
OTC Drugs As Tax Deductible Expenses Advocated By CHPA
Over-the-counter drug purchases should be classified as tax deductible medical expenses, the Consumer Healthcare Products Association contends
CHPA’s New President Suydam Brings Extensive FDA Experience To Post
Incoming Consumer Healthcare Products Association President Linda Suydam will provide the trade group with top-level ties to regulatory decision-makers and key federal legislators